Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 8/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.54 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.52 |
| ▸ | HRH2 | P25021 | 5/20 | 0.47 |
| ▸ | HRH1 | P35367 | 5/20 | 0.47 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.44 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.44 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.44 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.43 |
| ▸ | KIF11 | P52732 | 2/20 | 0.43 |
| ▸ | MMP3 | P08254 | 1/20 | 0.42 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.40 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.39 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11524397 | 1.00 | HRH3 (0.54) | HRH3KCNH2ESR2HRH2HRH1 | |
| SCHEMBL14649680 | 1.00 | HRH3 (0.54) | HRH3KCNH2ESR2HRH2HRH1 | |
| SCHEMBL14649679 | 0.95 | HRH3 (0.50) | HRH3KCNH2ESR2HRH2HRH1 | |
| SCHEMBL20083485 | 0.94 | ESR2 (0.57) | HRH3KCNH2ESR2HRH2HRH1 | |
| SCHEMBL30150 | 0.94 | ESR2 (0.57) | HRH3KCNH2ESR2HRH2HRH1 | |
| SCHEMBL16488063 | 0.94 | ESR2 (0.57) | HRH3KCNH2ESR2HRH2HRH1 | |
| SCHEMBL10766113 | 0.89 | ESR2 (0.52) | HRH3KCNH2ESR2HRH2HRH1 | |
| SCHEMBL10909714 | 0.89 | ESR2 (0.52) | HRH3KCNH2ESR2HRH2HRH1 | |
| SCHEMBL9338854 | 0.87 | HRH3 (0.44) | HRH3KCNH2ESR2HRH2HRH1 | |
| SCHEMBL9445453 | 0.87 | HRH3 (0.44) | HRH3KCNH2ESR2HRH2HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11584853-B2 | Dichroic dye and liquid crystal composition | DIC CORPORATION (JP) | 2023-02-21 | — | — | US | disclosed |
| EP-3434750-B1 | LIQUID-CRYSTAL COMPOSITION AND LIQUID-CRYSTAL DISPLAY ELEMENT | JNC CORP (JP) | 2020-11-18 | — | — | EP | disclosed |
| EP-3725764-A1 | POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | JNC Corporation (JP) | 2020-10-21 | — | — | EP | disclosed |
| WO-2020189209-A1 | LIQUID CRYSTAL COMPOSITE BODY AND LIQUID CRYSTAL LIGHT CONTROL ELEMENT | JNC株式会社 | 2020-09-24 | — | — | WO | disclosed |
| EP-3305774-B1 | BENZOTHIOPHENE-CONTAINING LIQUID CRYSTALLINE COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORP (JP) | 2020-08-26 | — | — | EP | disclosed |
| WO-2020158211-A1 | LIQUID CRYSTAL COMPOSITE BODY, LIQUID CRYSTAL LIGHT CONTROL ELEMENT AND LIGHT CONTROL WINDOW | JNC株式会社 | 2020-08-06 | — | — | WO | disclosed |
| EP-3406585-B1 | TETRACYCLIC LIQUID CRYSTAL COMPOUND HAVING DIATOMIC BONDING GROUP AND 2,3-DIFLUOROPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORP (JP) | 2020-07-29 | — | — | EP | disclosed |
| EP-3663379-A1 | LIQUID CRYSTAL COMPOSITE AND LIQUID CRYSTAL LIGHT CONTROL ELEMENT | JNC Corporation (JP) | 2020-06-10 | — | — | EP | disclosed |
| EP-3179303-B1 | LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORP (JP) | 2020-04-01 | — | — | EP | disclosed |
| WO-2020026583-A1 | LIQUID CRYSTAL COMPOUND COMPRISING BENZOTHIAZOLE RING AND CF2O LIGAND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC株式会社 | 2020-02-06 | — | — | WO | disclosed |
| EP-2502972-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2012-09-26 | — | — | EP | disclosed |
| EP-2366756-A2 | Liquid Crystal Composition and Liquid Crystal Display Element | JNC Corporation (JP) | 2011-09-21 | — | — | EP | disclosed |
| EP-2357218-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2011-08-17 | — | — | EP | disclosed |
| EP-2351741-A1 | PENTACYCLIC LIQUID CRYSTAL COMPOUND HAVING NITROGEN-CONTAINING HETEROCYCLIC RING, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | Chisso Corporation (JP) | 2011-08-03 | — | — | EP | disclosed |
| US-7951432-B2 | Five-ring liquid crystal compound having cyclohexane ring, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2011-05-31 | — | — | US | disclosed |
| US-20090302273-A1 | FIVE-RING LIQUID CRYSTAL COMPOUND HAVING CYCLOHEXANE RING, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | CHISSO CORPORATION (JP) | 2009-12-10 | — | — | US | disclosed |
| US-20090256114-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | CHISSO CORPORATION (JP) | 2009-10-15 | — | — | US | disclosed |
| EP-1939268-A1 | LIGHT-MODULATING LIQUID-CRYSTAL ELEMENT | Adeka Corporation (JP) | 2008-07-02 | — | — | EP | disclosed |
| EP-1788064-A1 | Liquid crystal composition and liquid crystal display device | CHISSO CORPORATION (JP) | 2007-05-23 | — | — | EP | disclosed |
| US-4154697-A | Liquid crystalline hexahydroterphenyl derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1979-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090302273-A1 | FIVE-RING LIQUID CRYSTAL COMPOUND HAVING CYCLOHEXANE RING, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | ZYX, PYM1, CPNE4 | HRH3 1368/4885KCNH2 783/4885ESR2 3315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.